Neuroone Medical Technologies (NMTC) Enterprise Value (2017 - 2026)

Neuroone Medical Technologies has reported Enterprise Value for 10 years, with the latest figure at -$2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 112.38% year-over-year to -$2.8 million; the trailing twelve-month figure through Mar 2026 stood at -$2.8 million (down 112.38% YoY), and the FY2025 full-year result was -$6.6 million, down 350.01% from the prior year.
• Enterprise Value for Q1 2026 stood at -$2.8 million, up from -$3.6 million in the prior quarter.
• The five-year high for Enterprise Value was -$1.1 million in Q4 2024, with the low at -$12.9 million in Q1 2022.
• Historically, Enterprise Value has averaged -$5.1 million across 5 years, with a median of -$3.6 million in 2025.
• Annual changes were most pronounced in 2024 — Enterprise Value surged 72.57% — and 2025, when it plunged 396.28%.
• Neuroone Medical Technologies' Enterprise Value stood at -$7.6 million in 2022, then soared by 64.92% to -$2.7 million in 2023, then jumped by 57.69% to -$1.1 million in 2024, then plunged by 217.36% to -$3.6 million in 2025, then advanced by 22.11% to -$2.8 million in 2026.
• The last three Enterprise Value figures came in at -$2.8 million (Q1 2026), -$3.6 million (Q4 2025), and -$6.6 million (Q3 2025), per Business Quant data.